NPI: 1164403861 · DOTHAN, AL 36301 · General Acute Care Hospital · NPI assigned 11/09/2005
Authorized official MILLER, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | MILLER, ROBERT (CFO) |
| NPI Enumeration Date | 11/09/2005 |
Other providers sharing the same authorized official: MILLER, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,562 | $585K |
| 2019 | 29,844 | $572K |
| 2020 | 17,067 | $369K |
| 2021 | 21,620 | $522K |
| 2022 | 24,311 | $690K |
| 2023 | 27,116 | $989K |
| 2024 | 21,623 | $1.20M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,499 | 24,690 | $1.71M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,058 | 2,883 | $962K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,752 | 21,207 | $827K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11,169 | 9,140 | $339K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 25,076 | 21,855 | $199K |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,072 | 8,750 | $95K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,914 | 2,738 | $62K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,396 | 1,328 | $59K |
| G0378 | Hospital observation service, per hour | 1,549 | 1,211 | $45K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,373 | 755 | $41K |
| 80053 | Comprehensive metabolic panel | 4,000 | 2,828 | $40K |
| 81001 | 9,986 | 9,247 | $37K | |
| 80076 | 5,877 | 5,381 | $36K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,906 | 3,442 | $35K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 873 | 337 | $33K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 248 | 214 | $31K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 738 | 683 | $29K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 472 | 229 | $28K |
| 80047 | 4,253 | 3,922 | $25K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,162 | 1,003 | $24K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 494 | 474 | $24K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 598 | 569 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,281 | 1,217 | $19K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 807 | 783 | $18K |
| J7050 | Infusion, normal saline solution, 250 cc | 765 | 313 | $17K |
| 71046 | Radiologic examination, chest; 2 views | 1,333 | 1,229 | $12K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 45 | 41 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | 130 | 118 | $10K |
| 84484 | 1,300 | 1,121 | $10K | |
| 87081 | 1,092 | 1,030 | $10K | |
| 71045 | Radiologic examination, chest; single view | 1,967 | 1,756 | $9K |
| 46505 | 42 | 42 | $9K | |
| 83735 | 1,146 | 987 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 200 | 195 | $8K |
| 87486 | 200 | 195 | $8K | |
| 87581 | 200 | 195 | $8K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 86 | 85 | $8K |
| 59025 | Fetal non-stress test | 1,243 | 924 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 224 | 62 | $5K |
| 81002 | 1,771 | 1,685 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 793 | 637 | $4K |
| 85014 | 4,506 | 4,094 | $4K | |
| 83690 | 671 | 607 | $4K | |
| 81025 | 1,099 | 1,028 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 45 | 43 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 330 | 257 | $3K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12 | 12 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,630 | 2,415 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 192 | 161 | $2K |
| 87420 | 138 | 128 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,895 | 1,598 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,175 | 1,044 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | 778 | 700 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 109 | 69 | $716.76 |
| 94664 | 108 | 105 | $602.86 | |
| 77336 | 36 | 13 | $445.06 | |
| 95812 | 14 | 13 | $424.06 | |
| 83605 | 42 | 38 | $403.56 | |
| 84702 | 26 | 25 | $395.37 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 43 | 41 | $214.37 |
| 87430 | 17 | 17 | $208.52 | |
| 87807 | 14 | 14 | $172.90 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 368 | 174 | $153.00 |
| 85610 | 28 | 26 | $141.52 | |
| 73110 | 12 | 12 | $136.44 | |
| 73610 | 13 | 12 | $136.44 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 542 | 369 | $116.07 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 101 | 53 | $65.00 |
| 87210 | 12 | 12 | $54.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 13 | 12 | $27.72 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 70 | 55 | $26.64 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 13 | 12 | $18.46 |
| 85027 | 13 | 12 | $10.76 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 405 | 318 | $5.41 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 557 | 545 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 173 | 168 | $0.00 |
| 94799 | 12 | 12 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 104 | 103 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 233 | 211 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 51 | 51 | $0.00 |
| 94760 | 95 | 92 | $0.00 | |
| 80320 | 84 | 79 | $0.00 | |
| 36591 | 274 | 148 | $0.00 |